Peter Schirmacher
- Pulmonary and Respiratory Medicine top 10%
- Oncology top 10%
- Cancer Research top 10%
- Molecular Biology
- Immunology
- Co-authors
- Michael ThomasManfred DietelFelix HerthMiquel TarónChristian ManegoldRafael RosellFred R. HirschDominique Grunenwald
- Topics
- Lung Cancer Treatments and Mutations (5 papers)Hepatocellular Carcinoma Treatment and Prognosis (4 papers)Pancreatic and Hepatic Oncology Research (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaGutBritish Journal of Cancer
- Partner nations
- GermanySwitzerlandAustria
In The Last Decade
Peter Schirmacher
14 papers receiving 464 citations
Hit Papers
Peers
Comparison fields: 5 of 53
- Pulmonary and Respiratory Medicine 265
- Oncology 239
- Cancer Research 189
- Molecular Biology 143
- Immunology 36
Countries citing papers authored by Peter Schirmacher
This map shows the geographic impact of Peter Schirmacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schirmacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schirmacher more than expected).
Fields of papers citing papers by Peter Schirmacher
This network shows the impact of papers produced by Peter Schirmacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schirmacher. The network helps show where Peter Schirmacher may publish in the future.
Co-authorship network of co-authors of Peter Schirmacher
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Schirmacher. A scholar is included among the top collaborators of Peter Schirmacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Schirmacher. Peter Schirmacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 20 | |
| 7 | 14 | |
| 8 | Tumour mutational burden: clinical utility, challenges and emerging improvementsbreakdown → | 47 |
| 9 | 3 | |
| 10 | 2 | |
| 11 | 6 | |
| 12 | 13 | |
| 13 | 29 | |
| 14 | 228 | |
| 15 | 44 | |
| 16 | 42 | |
| 17 | 20 |
About Peter Schirmacher
Peter Schirmacher is a scholar working on Hepatology, Oncology and Cancer Research, having authored 17 papers that have together received 470 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Cancer Research (189 citations), Oncology (239 citations) and Pulmonary and Respiratory Medicine (265 citations). Peter Schirmacher has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include Michael Thomas, Manfred Dietel, Felix Herth, Miquel Tarón, Christian Manegold, Rafael Rosell, Fred R. Hirsch, Dominique Grunenwald, Keith M. Kerr and Helmut Popper. Their work appears in journals such as SHILAP Revista de lepidopterología, Gut and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.